Companies / Inhibitor Therapeutics, Inc.

Inhibitor Therapeutics, Inc.

OTC: INTICIK 1042418TAMPA, FL

Financials · FY2021

Revenue$0
Net income$-3.30M
Total debt—
Cash$1.29M
Diluted EPS$-0.02
Shares outstanding172.6M

Ownership

172.6M shares outstanding · as of May 15, 2026
0.22%Insiders
Ownership
Insiders0.22%380,411
Public float99.78%172,193,134

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 2

View all →
Insider% of sharesShares
Vasisht NirajDirector
0.12%200,000
Jerman Michael AllenDirector
0.10%180,411

Institutional holders 0

HolderValue% of shares
No institutional holders on file.

Activity

View all →
InsidersInstitutions
What insiders are doing in this stock (Form 4).
DateActorActionSecurityValueShares ΔPosition afterImpact
May 4, 2026Jerman Michael Allen
Director
GrantCommon Stock$0+50K
+38.34%
180,411
0.10% of shares
low
May 5, 2026Vasisht Niraj
Director
GrantCommon Stock$0+50K
+33.33%
200,000
0.12% of shares
low